Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Formulations in Persistent Asthma
NCT01484197Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Started Nov 2011; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01484197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484197.